Neo Urinary Conduit

Related by string. * NEO . NEOs . Neos . NEOS : neo liberal policies . Neo Kidney Augment . Tengion Neo Bladder Augment . neo liberal / urinary : urinary tract infections . urinary tract symptoms . acute urinary retention . urge urinary incontinence / Conduits . CONDUIT . conduit . conduits : Relief Fittings Conduit . CMBS conduit . ABCP conduits . investment conduits REMICs * Tengion Neo Urinary Conduit *

Related by context. Frequent words. (Click for all words.) 67 MOZOBIL 65 anticancer compound 65 Omigard 64 Allovectin 7 R 64 Chrysalin 64 TOCOSOL Paclitaxel 64 Bone Graft 63 MAXY G# 63 sodium Injection 63 KNS # 63 Stedivaze 62 active cellular immunotherapy 62 Azedra 62 BrachySil 61 tivozanib 61 vernakalant oral 61 Zelrix 61 pralatrexate 61 Anturol 61 Chemokine Therapeutics 61 Topical Interferon Alpha 2b 61 Genasense R oblimersen 61 ApoB SNALP 61 ALN TTR# 60 Genitope Corporation 60 CCX# 60 registrational 60 rNAPc2 60 confirmatory Phase III 60 PEGylation technology 60 LightTouch 60 TELCYTA 60 DAVANAT R 60 IND submission 60 cangrelor 60 HCV protease inhibitor 60 Phase 2a clinical 59 CoFactor 59 Picoplatin 59 Investigational Device Exemption IDE 59 ALN VSP 59 Regado 59 Onalta 59 MONOVISC 59 BLA submission 59 CR# vcMMAE 59 HepaLife 59 liprotamase 59 Zerenex 58 OncoVEX GM CSF 58 orBec R 58 Novacor LVAS 58 HspE7 58 Marqibo 58 refractory Hodgkin lymphoma 58 Phenoptin 58 registrational trial 58 anticancer agent 58 pseudobulbar affect PBA 58 Cotara R 58 Phase 2b trial 58 ELND# 58 DB# [003] 58 Phase 2a trial 58 thymalfasin 58 BiTE antibody 58 APF# 58 Virulizin R 58 FavId 58 Icatibant 58 autologous cell 58 Metastatic Melanoma 58 Phase 2b clinical 58 DR Cysteamine 57 PREOS 57 Cobalamin 57 fibrin sealant 57 Sernova 57 MGCD# [001] 57 Cethrin 57 NexACT 57 autologous bone marrow 57 talactoferrin 57 Sym# 57 deforolimus 57 Investigational Device Exemption 57 Phase 2b study 57 Phase III clinical 57 maribavir 57 tanespimycin 57 Neuradiab 57 OXi# 57 prGCD 57 MAP# 57 Intermezzo R 57 tezampanel 57 AVN# [001] 57 therapeutic monoclonal antibodies 56 BAY #-# 56 elotuzumab 56 oral formulation

Back to home page